HRT Claims Surge 228% Among Canadian Women in Prime Working Years — Manulife Financial Corporation

Event summary

HRT claims among Canadian women aged 45–54 rose 228% over five years, per Manulife data.
Claims also increased 46% for women aged 35–44 and 66% for those aged 55–64.
Manulife expanded access to Maven Clinic’s Menopause program for 1.4M Group Benefits members.
Unmanaged menopause symptoms cost the Canadian economy $3.5B annually.

The big picture

Manulife’s data highlights a growing recognition of menopause as a workplace issue, with HRT emerging as a key tool for managing symptoms. The surge in claims reflects broader trends in women’s health awareness and employer-driven benefits innovation. With unmanaged menopause costing the Canadian economy billions, insurers and employers are increasingly aligning to address this gap.

What we're watching

Workforce Impact: How sustained HRT adoption will affect productivity and retention of women in peak working years.
Regulatory Shifts: Whether evolving HRT safety guidelines will influence employer benefits strategies.
Market Expansion: The pace at which insurers integrate menopause support into broader health offerings.